Author

Yanyan Lou

Mayo Clinic in FloridaORCID 0000-0001-6207-9461Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yanyan Lou1 paper · Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clinic Jacksonville, FL, USA;

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Assay:proteomics· 1

Frequent Co-Authors

Abhijeet Prasad· 1 shared Aishwarya SuniliD· 1 shared Alfredo Quiñones‐HinojosaiD· 1 shared Amreen NasreeniD· 1 shared Andrea Otamendi-Lopez· 1 shared Andreas FriedliD· 1 shared Andrew K. GodwiniD· 1 shared Anna V. KellneriD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhijeet Prasad

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal of Translational MedicinePeer-reviewedJan 3, 2026

A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity

T. S. Ramasubramanian, Pichet Adstamongkonkul, Christina M. Scribano…·Hinco Jasper Gierman

This paper introduces a live tumor fragment platform to assess immunotherapy response in core needle biopsies, showing it can detect T-cell responses and mitigate tissue heterogeneity challenges.

6 citationstop 1%

humanproteomics

𝕏 PostBluesky

Cancer BiologyMolecular Therapy OncologyPeer-reviewedOct 5, 2024

Advancing CAR T-Cell Therapy: Simultaneously Attack Tumor and Immunosuppressive Cells in the Tumor Microenvironment

Yan Luo, Martha E. Gadd, Yaqing Qie…·Hong Qin

This paper develops a PD-L1-targeting CAR T-cell therapy (MC9999) that effectively attacks both tumor and immunosuppressive cells in solid tumors.

19 citations

𝕏 PostBluesky